Published in Int J Tuberc Lung Dis on September 07, 2012
Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. J Infect Dis (2014) 1.65
Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC Infect Dis (2014) 0.92
Alcohol use and its association with HIV risk behaviors among a cohort of patients attending HIV clinical care in Tanzania, Kenya, and Namibia. AIDS Care (2014) 0.83
Psychosocial functioning and depressive symptoms among HIV-positive persons receiving care and treatment in Kenya, Namibia, and Tanzania. Prev Sci (2014) 0.81
AUDIT, AUDIT-C, and AUDIT-3: drinking patterns and screening for harmful, hazardous and dependent drinking in Katutura, Namibia. PLoS One (2015) 0.79
Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review. PLoS One (2016) 0.78
Delivering Prevention Interventions to People Living with HIV in Clinical Care Settings: Results of a Cluster Randomized Trial in Kenya, Namibia, and Tanzania. AIDS Behav (2016) 0.75
Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health (2016) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci (2007) 5.62
Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32
The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health (2009) 2.39
Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ (2007) 2.09
A population-based study on alcohol and high-risk sexual behaviors in Botswana. PLoS Med (2006) 1.95
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis (2006) 1.91
The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med (2007) 1.70
Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int J Tuberc Lung Dis (2008) 1.64
Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics (2007) 1.64
Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis (2008) 1.29
Integration of alcohol use disorders identification and management in the tuberculosis programme in Tomsk Oblast, Russia. Eur J Public Health (2008) 1.21
Screening and brief interventions for hazardous and harmful alcohol use among patients with active tuberculosis attending primary care clinics in South Africa: a cluster randomized controlled trial protocol. BMC Public Health (2011) 1.16
Alcohol and risks for HIV/AIDS among sexually transmitted infection clinic patients in Cape Town, South Africa. Subst Abus (2006) 1.14
Alcohol use disorders (AUD) among tuberculosis patients: a study from Chennai, South India. PLoS One (2011) 1.05
Alcohol consumption among men and women with tuberculosis in Tomsk, Russia. Cent Eur J Public Health (2010) 0.98
Performance of the alcohol use disorders identification test among tuberculosis patients in Russia. Subst Use Misuse (2010) 0.92
Alcohol use and clinical manifestations of tuberculosis. J Infect (2008) 0.89
HIV risk factors among patients with tuberculosis--Botswana 1999. Int J STD AIDS (2002) 0.87
Alcohol brewing and the African tuberculosis epidemic. Med Anthropol (2011) 0.79
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell (1996) 14.64
A special-purpose processor for gene sequence analysis. Comput Appl Biosci (1993) 7.24
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
The influence of patient-practitioner agreement on outcome of care. Am J Public Health (1981) 4.08
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell (1996) 3.44
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol (1997) 2.51
Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes (1998) 2.44
Systematic relationships and cospeciation of bacterial endosymbionts and their carpenter ant host species: proposal of the new taxon Candidatus Blochmannia gen. nov. Int J Syst Evol Microbiol (2000) 2.35
Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation. Am J Clin Nutr (1996) 2.32
Low compliance with an iron-supplementation program: a study among pregnant women in Jakarta, Indonesia. Am J Clin Nutr (1993) 2.20
Liberation of surface-located penicillinase from Staphylococcus aureus. Biochem J (1967) 2.07
Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patient. Br J Psychiatry (1997) 2.02
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol (1998) 1.95
Intracellular endosymbiotic bacteria of Camponotus species (carpenter ants): systematics, evolution and ultrastructural characterization. Mol Microbiol (1996) 1.95
Plasmid and chromosomal mutants in the iron(III)-aerobactin transport system of Escherichia coli. Use of streptonigrin for selection. Mol Gen Genet (1983) 1.80
Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol (2001) 1.76
Evolutionary trends in the genus Bordetella. Microbes Infect (2001) 1.72
Identification of the genes and their polypeptide products responsible for aerobactin synthesis by pColV plasmids. Mol Gen Genet (1985) 1.68
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J Clin Invest (1999) 1.61
Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization. J Clin Microbiol (1988) 1.57
The effect of acute severe illness on CD4+ lymphocyte counts in nonimmunocompromised patients. Arch Intern Med (2000) 1.55
HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci U S A (2000) 1.53
Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J Virol (1998) 1.50
Difficult airway in a patient with Coffin-Siris syndrome. Anesth Analg (2001) 1.48
Signalling pathways in two-component phosphorelay systems. Trends Microbiol (1999) 1.47
An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol (1998) 1.45
Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol (1996) 1.44
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol (1998) 1.43
The virulence regulator protein of Listeria ivanovii is highly homologous to PrfA from Listeria monocytogenes and both belong to the Crp-Fnr family of transcription regulators. Mol Microbiol (1994) 1.43
Genetic and biochemical characterization of the aerobactin synthesis operon on pColV. Mol Gen Genet (1984) 1.42
Time trends and autism. Isr Med Assoc J (2009) 1.41
Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology (1995) 1.41
Identification of mycobacteria to the species level by automated restriction enzyme fragment length polymorphism analysis. Virchows Arch (1995) 1.36
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A (2001) 1.36
A prospective study of enteropathogenic Escherichia coli in endemic diarrheal disease. J Infect Dis (1978) 1.35
Activation of cyclophosphamide in man and animals. Cancer (1971) 1.34
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption. J Infect Dis (2000) 1.33
Specificity of the BvgAS and EvgAS phosphorelay is mediated by the C-terminal HPt domains of the sensor proteins. Mol Microbiol (1998) 1.31
Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol (1998) 1.28
Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule. J Cardiovasc Pharmacol (1985) 1.27
Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest (2001) 1.26
Chemokine receptors and HIV. J Leukoc Biol (1997) 1.25
Regulation of adenosine 3':5'-monophosphate content in human astrocytoma cells by adenosine and the adenine nucleotides. J Biol Chem (1974) 1.24
Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. Proc Natl Acad Sci U S A (1995) 1.24
V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J Virol (1995) 1.24
Premature complementary feeding is associated with poorer growth of vietnamese children. J Nutr (2000) 1.24
Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun (2000) 1.23
Characterization of an IS-like element from Mycobacterium tuberculosis. J Gen Microbiol (1993) 1.23
Characterization of a bordetella pertussis diaminopimelate (DAP) biosynthesis locus identifies dapC, a novel gene coding for an N-succinyl-L,L-DAP aminotransferase. J Bacteriol (2000) 1.21
Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies. J Virol (2000) 1.21
Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr (2000) 1.20
Effect of mutations causing overexpression of RNA polymerase alpha subunit on regulation of virulence factors in Bordetella pertussis. J Bacteriol (1994) 1.20
Adenosine triphosphatase in isolated membranes of Staphylococcus aureus. J Bacteriol (1968) 1.18
Correlates of a perceived need for mental health assistance and differences between those who do and do not seek help. Soc Psychiatry Psychiatr Epidemiol (1999) 1.16
Hydroxyethyl starch: an agent for hypovolemic shock treatment. J Surg Res (1977) 1.16
Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition. J Lab Clin Med (1979) 1.16
Influence of organic anions on the liberation of penicillinase from Staphylococcus aureus. Biochem J (1967) 1.16
Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation (1991) 1.16
4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. Eur J Pharmacol (2000) 1.15
A NapC/NirT-type cytochrome c (NrfH) is the mediator between the quinone pool and the cytochrome c nitrite reductase of Wolinella succinogenes. Mol Microbiol (2000) 1.15
Genome interdependence in insect-bacterium symbioses. Genome Biol (2001) 1.15
The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav (2000) 1.14
Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology (1995) 1.14
Effect of daily vs twice weekly iron supplementation in Indonesian preschool children with low iron status. Am J Clin Nutr (1995) 1.13
In vivo characterization of the unorthodox BvgS two-component sensor protein of Bordetella pertussis. J Mol Biol (1995) 1.13
Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology (1996) 1.12
Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Eur J Pharmacol (1993) 1.11
Enterotoxigenic Escherichia coli in central Canada. J Clin Microbiol (1980) 1.11
Decreased rate of stunting among anemic Indonesian preschool children through iron supplementation. Am J Clin Nutr (1993) 1.10
The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun (1998) 1.10
[An in vitro method for the autoradiographic determination of the cell kinetics of erythroblasts in animals and humans]. Histochemie (1970) 1.10
A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression. J Bacteriol (1993) 1.09
4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol (1999) 1.09
The effect of mitomycin C on the induced synthesis of penicillinase in Staphylococcus aureus. Biochem Biophys Res Commun (1965) 1.09
Matrilinear phylogeography of Atlantic salmon (Salmo salar L.) in Europe and postglacial colonization of the Baltic Sea area. Mol Ecol (2001) 1.09
Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem (2002) 1.09
Effective community intervention to improve hemoglobin status in preschoolers receiving once-weekly iron supplementation. Am J Clin Nutr (1997) 1.08
Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood. J Virol (1999) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08
Epithelial cell invasion and survival of Bordetella bronchiseptica. Infect Immun (1994) 1.07
4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes (1998) 1.07
A new gene locus of Bordetella pertussis defines a novel family of prokaryotic transcriptional accessory proteins. J Bacteriol (1996) 1.07
Organ- and age-specific replication of polyomavirus in mice. J Virol (1992) 1.06
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. Am J Ophthalmol (2000) 1.06
A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion. Diabetes (2001) 1.06
High-dose MTX/5-FU and adriamycin for gastric cancer. Semin Oncol (1983) 1.05
Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry (2003) 1.05
Weekly supplementation with iron and vitamin A during pregnancy increases hemoglobin concentration but decreases serum ferritin concentration in Indonesian pregnant women. J Nutr (2001) 1.05
Exopenicillinase synthesis in Staphylococcus aureus. J Bacteriol (1969) 1.04
Evolution of the Fermi surface of the electron-doped high-temperature superconductor Nd(2-x)Ce(x)CuO(4) revealed by Shubnikov-de Haas oscillations. Phys Rev Lett (2009) 1.04
A third crystal form of Wolinella succinogenes quinol:fumarate reductase reveals domain closure at the site of fumarate reduction. Eur J Biochem (2001) 1.03
Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol (2010) 1.02